This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de Wit, E. Articles by Fouchier, R. A. M. Search for Related Content PubMed PubMed Citation Articles by de Wit, E. Articles by Fouchier, R. A. M. Pubmed/NCBI databases Substance via MeSH

 Previous Article  |  Next Article 

Journal of Virology, October 2005, p. 12401-12407, Vol. 79, No. 19
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.19.12401-12407.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Protection of Mice against Lethal Infection with Highly Pathogenic H7N7 Influenza A Virus by Using a Recombinant Low-Pathogenicity Vaccine Strain

Emmie de Wit,^1,2, Vincent J. Munster,^1, Monique I. J. Spronken,^1,2 Theo M. Bestebroer,¹ Chantal Baas,¹ Walter E. P. Beyer,¹ Guus F. Rimmelzwaan,¹ Albert D. M. E. Osterhaus,¹ and Ron A. M. Fouchier^1*

National Influenza Center and Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands,¹ Solvay Pharmaceuticals B.V., Weesp, The Netherlands²

Received 8 April 2005/ Accepted 30 June 2005

In 2003, an outbreak of highly pathogenic avian influenza occurred in the Netherlands. The avian H7N7 virus causing the outbreak was also detected in 88 humans suffering from conjunctivitis or mild respiratory symptoms and one person who died of pneumonia and acute respiratory distress syndrome. Here we describe a mouse model for lethal infection with A/Netherlands/219/03 isolated from the fatal case. Because of the zoonotic and pathogenic potential of the H7N7 virus, a candidate vaccine carrying the avian hemagglutinin and neuraminidase proteins produced in the context of the high-throughput vaccine strain A/PR/8/34 was generated by reverse genetics and tested in the mouse model. The hemagglutinin gene of the recombinant vaccine strain was derived from a low-pathogenicity virus obtained prior to the outbreak from a wild mallard. The efficacy of a classical nonadjuvanted subunit vaccine and an immune stimulatory complex-adjuvanted vaccine was compared. Mice receiving the nonadjuvanted vaccine revealed low antibody titers, lack of clinical protection, high virus titers in the lungs, and presence of virus in the spleen, liver, kidneys, and brain. In contrast, mice receiving two doses of the immune stimulatory complex-adjuvanted vaccine revealed high antibody titers, clinical protection, 1,000-fold reduction of virus titers in the lungs, and rare detection of the virus in other organs. This is the first report of an H7 vaccine candidate tested in a mammalian model. The data presented suggest that vaccine candidates based on low-pathogenicity avian influenza A viruses, which can be prepared ahead of pandemic threats, can be efficacious if an effective adjuvant is used.

---

* Corresponding author. Mailing address: Department of Virology, Erasmus Medical Center, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. Phone: 31104088066. Fax: 31104089485. E-mail: r.fouchier{at}erasmusmc.nl.

E.D.W. and V.J.M. have contributed equally to the results of this study.

---

Journal of Virology, October 2005, p. 12401-12407, Vol. 79, No. 19
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.19.12401-12407.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Belser, J. A., Blixt, O., Chen, L.-M., Pappas, C., Maines, T. R., Van Hoeven, N., Donis, R., Busch, J., McBride, R., Paulson, J. C., Katz, J. M., Tumpey, T. M. (2008). Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility. Proc. Natl. Acad. Sci. USA 105: 7558-7563 [Abstract] [Full Text]  
• Pappas, C., Matsuoka, Y., Swayne, D. E., Donis, R. O. (2007). Development and Evaluation of an Influenza Virus Subtype H7N2 Vaccine Candidate for Pandemic Preparedness. CVI 14: 1425-1432 [Abstract] [Full Text]  
• Belser, J. A., Lu, X., Maines, T. R., Smith, C., Li, Y., Donis, R. O., Katz, J. M., Tumpey, T. M. (2007). Pathogenesis of Avian Influenza (H7) Virus Infection in Mice and Ferrets: Enhanced Virulence of Eurasian H7N7 Viruses Isolated from Humans. J. Virol. 81: 11139-11147 [Abstract] [Full Text]  
• Joseph, T., McAuliffe, J., Lu, B., Jin, H., Kemble, G., Subbarao, K. (2007). Evaluation of Replication and Pathogenicity of Avian Influenza A H7 Subtype Viruses in a Mouse Model. J. Virol. 81: 10558-10566 [Abstract] [Full Text]